Emi Gonzalez
Senior Principal @ Joyance Partners
Boston, United States
Emi Gonzalez is a seed investor at Joyance Partners in Boston focused on Medical and Software. Emi Gonzalez is the Investment Partner at Joyance Partners. She attended Harvard University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Emi Gonzalez invests in
Stages Emi Gonzalez invests in
Countries Emi Gonzalez invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (50%)
- Software 1 (50%)
- Biopharma 1 (50%)
- Health Care 1 (50%)
- Life Science 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| BioAesthetics was founded in 2015 as a Tulane University spin-out with the mission to improve reconstruction options for breast cancer patients after they undergo mastectomies. The BioAesthetics’ initial product is a tissue-engineered nipple-areolar complex (NAC). This product will be provided to plastic and reconstructive surgeons as anoff-the-shelf ready, acellular, NAC graft. During the breast reconstruction phase, after a mastectomy, the surgeon would engraft the NAC graft in position onto the patient’s reconstructed breast. The patient’s body would then use this NAC graft as a building frame to regenerate their own NAC. This patent-pending product is currently in the pre-clinical phase. | $6.4M / Series A / Oct 05, 2020 | ||
| Dyad Medical develops software that automatically analyzes the content of cardiac and cardiovascular images. Its software applications support both treatment decision making in the clinic and analysis in research, enabling researchers to optimize observations and conclusions. It was founded in 2018 and headquartered in Boston, Massachusetts. | $3.5M / Seed / Oct 02, 2020 |
Co-Investors
About Joyance Partners
Joyance Partners invests in companies that, through science and tech, cultivate joy to improve how we live, focusing on the health and consumer sectors from Pre-Seed to Series A.
Joyance Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Holly Jacobus
Investment Partner
|
|||
Andrew Nealon
Chief Analyst
|
|||
Charles Smith
Venture Partner
|
|||
Charles Smith
Venture Partner
|
|||
Claire Cherry
Investment Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Emi Gonzalez invest in?
Emi Gonzalez invests primarily in Medical, Software and Biopharma startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Emi Gonzalez?
Public channels for Emi Gonzalez include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Emi Gonzalez last invest?
The most recent investment recorded for Emi Gonzalez closed in Oct 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
